ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Tactile …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Tactile Systems Technology, Inc. (NASDAQ: TCMD) between May 7, 2018 and June 8, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Tactile investors under the federal securities laws.

To join the Tactile class action, go to http://www.rosenlegal.com/cases-register-1872.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

The complaint filed in this class action alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically,

Read More

Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Against Aurora Cannabis, Inc. (ACB)

BENSALEM, Pa.–(BUSINESS WIRE)–Oct 9, 2020–

Law Offices of Howard G. Smith reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”).

Investors suffering losses on their Aurora investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected].

On September 8, 2020, the Company announced that it expected to record up to $1.8 billion in goodwill impairment charges in fourth quarter 2020. According to Aurora’s press release, these charges included “up to $90 million” in fixed asset impairment charges “due to production facility rationalization, and a charge of approximately $140 million in

Read More

DEADLINE ALERT for HDB, UPLCQ, LX, YAYO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders.

 Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected]

HDFC Bank Limited 
Class Period: July 31, 2019 – July 10, 2020
Lead Plaintiff Deadline: November 2, 2020

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) HDFC Bank had inadequate disclosure controls and procedures and internal control over financial reporting; (2) as a

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Peabody Energy Corporation (BTU) Investors

LOS ANGELES, Oct. 9, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Peabody Energy Corporation (“Peabody” or the “Company”) (NYSE: BTU) common stock between April 3, 2017 and October 28, 2019, inclusive (the “Class Period”).  Peabody investors have until November 27, 2020to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On September 28, 2018, Peabody announced that it did “not expect any production from North Goonyella in the fourth quarter of 2018” due to a fire occurring within the mine.

On this news, the Company’s stock price fell $5.54, or over 13%, to close at $35.64 per share on September 28, 2018, thereby injuring investors.

Then, on February 6, 2019,

Read More

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cabot Oil & Gas Corporation (COG) – Press Release

LOS ANGELES–(Business Wire)–The Law Offices of Frank R. Cruz reminds investors of the upcoming October 13, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Cabot Oil & Gas Corporation (“Cabot Oil” or “the Company”) (NYSE: COG) securities between October 23, 2015 and June 12, 2020, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

On July 26, 2019, the Company disclosed that it had received two proposed Consent Order and Agreements related to two Notices of Violation it had received from the Pennsylvania Department of Environmental Protection in 2017 for failure to prevent the migration of gas into fresh groundwater sources in the area surrounding Susquehanna County, Pennsylvania.

On this news, the Company’s share price fell $2.63, or over 12%, to close at $19.16 per share on July 26, 2019.

On

Read More

The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Mesoblast Limited (MESO)

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Kristal v. Mesoblast Limited, et al., (Case No. 1:20-cv-08430), on behalf of persons and entities that purchased or otherwise acquired Mesoblast Limited (“Mesoblast” or the “Company”) (NASDAQ: MESO) securities between April 16, 2019 and October 1, 2020, inclusive (the “Class Period”). Plaintiff pursues under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”)

If you are a shareholder who suffered a loss, click here to participate.

Mesoblast develops allogeneic cellular medicines using its proprietary mesenchymal lineage cell therapy platform. Its lead product candidate, RYONCIL (remestemcel-L), is an investigational therapy comprising mesenchymal stem cells derived from bone marrow. In February 2018, the Company announced that remestemcel-L met its primary endpoint in a Phase 3 trial

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Nikola Corporation (NKLA) Investors

LOS ANGELES, Oct. 8, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Nikola Corporation f/k/a VectoIQ Acquisition Corp. (“Nikola” or “VectoIQ” or the “Company”) (NASDAQ: NKLA) securities between March 3, 2020 and September 15, 2020, inclusive (the “Class Period”). Nikola investors have until November 16, 2020to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On September 10, 2020, Hindenburg Research published a report entitled “Nikola: How to Parlay an Ocean of Lies into a Partnership with the Largest Auto OEM in America.” Therein, Hindenburg alleged that the Company’s founder, Trevor Milton, had misled partners into signing agreements by falsely claiming to have extensive proprietary technology. Among other things, the report claimed that Milton

Read More

Portnoy Law Advises Last Days to Participate Actively in the Class …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Investors with a $100,000 or more in losses
are encouraged to contact the firm before October 19, 2020; click

here

to submit trade information

​LOS ANGELES, Oct. 08, 2020 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Qutoutiao, Inc. (NASDAQ: QTT) investors that acquired shares between September 14, 2018 and July 15, 2020. Investors have until October 19, 2020 to seek an active role in this litigation.

Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case.

It is alleged within the complaint filed in this class action that Defendants made materially misleading and/or false statements, as

Read More

DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Golar LNG Limited (GLNG)

BENSALEM, Pa., Oct. 7, 2020 /PRNewswire/ — ­Law Offices of Howard G. Smith reminds investors of the upcoming November 24, 2020deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Golar LNG Limited (“Golar” or the “Company”) (NASDAQ: GLNG) securities between April 30, 2020 and September 24, 2020, inclusive (the “Class Period”).  

Investors suffering losses on their Golar investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected].

On September 24, 2020, media reported that the Chief Executive Officer (“CEO”) of Golar’s joint venture, Hygo Energy Transition Ltd. (“Hygo”), was involved in a bribery network investigated in Brazil’s Operation Car Wash.

On this news, Golar’s share price fell $3.28, or 32%, to close at $6.86 per share on

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NextCure, Inc. (NXTC) Investors

LOS ANGELES, Oct. 6, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired NextCure, Inc. (“NextCure” or the “Company”) (NASDAQ: NXTC): (a) securities between November 5, 2019 and July 14, 2020, inclusive (the “Class Period”); and/or (b) common stock pursuant or traceable to the Company’s November 2019 secondary public offering (“SPO” or the “Offering”). NextCure investors have until November 20, 2020 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

In November 2019, NextCure completed its SPO, selling over 4 million shares at $36.75 per share.

On January 13, 2020, NextCure disclosed that Eli Lilly and Company had ended its collaboration agreement for the research and development of the Company’s leading product candidate, NC318, a

Read More